Ilya Reyter, MD
MOHS-Micrographic Surgery · Sherman Oaks, CANPI 1558456517
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,303 of the $4,848 with a category attached, or 88.8%. It is spread thinly across 24 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,185 and has fallen 51.6% since, to $574 in 2025.
Across 200 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$800
- Galderma Laboratories, L.p.$590
- Novartis$564
- Biofrontera Inc.$304
- Incyte Corporation$296
- plus $1K from 18 others
What the payments were for
- Speaking & faculty fees$4509%
- Food & beverage$4,30389%
- Education$952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $1,104 |
| Sanofi | 23 | $800 |
| Galderma Laboratories, L.p. | 10 | $590 |
| Novartis | 27 | $564 |
| Biofrontera Inc. | 13 | $304 |
| Incyte Corporation | 14 | $296 |
| Johnson & Johnson | 8 | $271 |
| Regeneron Healthcare Solutions, Inc. | 9 | $249 |
| Sun Pharmaceutical Industries Inc. | 8 | $174 |
| UCB, Inc. | 4 | $107 |
| Dermavant Sciences, Inc. | 3 | $70 |
| Almirall LLC | 2 | $55 |
| DUSA Pharmaceuticals, Inc. | 2 | $51 |
| EPI Health, LLC | 2 | $27 |
| Mission Pharmacal Company | 1 | $26 |
| Amgen | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Bristol Myers Squibb | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
| Pfizer | 1 | $13 |
How this compares
$4,848 in reported general payments places this provider in the 65th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imiquimod | 16 | $514 |
| Cephalexin | 36 | $106 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Sherman Oaks
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
- Frank NoodlemanSaratoga$19K
- Howard FeinRolling Hills Estates$19K
- Joanna ChanLong Beach$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.